S.A. Mason LLC Organon & Co. Transaction History

S.A. Mason LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$16.59 - $23.77 $6,685 - $9,579	403 Added 47.58%	1,250 $21,000
Q1 2023 May 10, 2023	SELL	$21.42 - $32.08 $42 - $64	-2 Reduced 0.24%	847 $19,000
Q4 2022 Jan 10, 2023	BUY	$23.31 - $28.61 $5,174 - $6,351	222 Added 35.41%	849 $0
Q3 2022 Oct 20, 2022	BUY	$23.4 - $34.25 $23 - $34	1 Added 0.16%	627 $15,000
Q2 2022 Jul 07, 2022	SELL	$31.66 - $38.9 $348 - $427	-11 Reduced 1.73%	626 $21,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $548 - $708	-18 Reduced 2.75%	637 $22,000
Q4 2021 Jan 04, 2022	BUY	$28.67 - $37.13 $28 - $37	1 Added 0.15%	655 $20,000
Q3 2021 Oct 12, 2021	BUY	$28.63 - $35.64 $18,724 - $23,308	654 New	654 $21,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

Stay updated on S.A. Mason LLC with notifications on news.